Skip to main content
. 2022 Mar 14;20:127. doi: 10.1186/s12967-022-03311-z

Table 1.

Clinicopathological characteristics of esophageal squamous cell carcinoma patients

Characteristics Esophageal squamous cell carcinoma TNM Stage
TNM Stage I (N = 15) TNM Stage II (N = 15) TNM Stage III (N = 15) TNM Stage IV (N = 15) Adjacent cancerous tissues (N = 15)
Age
 < 65—no. (%) 6 (40.0) 5 (33.3) 9 (60.0) 7 (46.7) 11 (73.3)
 ≥ 65—no. (%) 9 (60.0) 10 (66.7) 6 (40.0) 8 (53.3) 4 (26.7)
Genders
 Female—no. (%) 3 (20.0) 4 (26.7) 1 (6.7) 2 (13.3) 5 (33.3)
 Male—no. (%) 12 (80.0) 11 (73.3) 14 (93.3) 13 (86.7) 10 (66.7)
Body-mass index
 Median (IQR) 20.8 (19.3–22.5) 20.3 (18.2–22.4) 19.2 (18.2–20.6) 18.6(17.6–19.2) 21.3 (19.9–23.2)
Tumor locationa
 Lt—no. (%) 3 (20.0) 5 (33.3) 9 (60.0) 6 (40.0)
 Mt—no. (%) 10 (66.7) 7 (46.7) 5 (33.3) 7 (46.7)
 Ut—no. (%) 2 (13.3) 3 (20.0) 1 (6.7) 2 (13.3)

Lt lower thoracic esophagus, Mt middle thoracic esophagus, Ut upper thoracic esophagus

aTumor location was classified according to the Union for International Cancer Control Tumor, Node, Metastasis cancer staging system (ninth edition)